SoftWave TRT

SoftWave TRT

Shockwave therapy devices for tissue healing

Overview

SoftWave TRT is a medical technology company focused on shockwave therapy to aid tissue healing and regeneration. Its devices emit low‑to‑moderate energy acoustic shocks that are applied to injured or painful areas, stimulating biological responses to speed healing, reduce pain, and improve function. The therapy is used across orthopedics, traumatology, wound care, aesthetics, and urology, and is backed by clinical studies and adoption by major medical centers. What sets SoftWave apart is its governance of a German‑engineered platform with manufacturing partners and a track record of more than 300 published studies, along with international recognition from ISMST and a broad global footprint. The company’s goal is to advance scientific knowledge and provide effective, accessible treatments to improve patients’ quality of life around the world.

About SoftWave TRT

Simplify's Rating
Why SoftWave TRT is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Industrial & Manufacturing

Healthcare

Company Size

1-10

Company Stage

N/A

Total Funding

N/A

Headquarters

Woodstock, Georgia

Founded

2005

Get referred to SoftWave TRT

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • September 2026 VA contract expands veteran access across pain and wound care.
  • SoftWave's June 2026 government-sales page says military treatment facilities already use it.
  • FDA records show K233937 became substantially equivalent on July 9, 2024.

What critics are saying

  • SoftWave's clearances remain indication-specific, not blanket approval for every chronic-pain claim.
  • Shockwave competitors like Chattanooga, Storz, and ZIMMER crowd clinics and dealer channels.
  • If VA utilization stalls, government adoption becomes a stranded-contract story by 2028.

What makes SoftWave TRT unique

  • SoftWave TRT holds VA Federal Supply Schedule access through July 14, 2028.
  • Its FDA-cleared OW100S targets diabetic foot ulcers, burns, pain, and circulation.
  • January 2026 leadership added Mark Gilreath, Tom Rhoads, and Luke Olson.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Company News

Samachar Live
Aug 2nd, 2023
SoftWave TRT lands prestigious VA Contract revolutionizing pain and wound management for Veterans

In an important step forward for veterans’ healthcare, SoftWave Tissue Regeneration Technologies (SoftWave TRT) has been awarded a Federal Supply Schedule Contract by the Department of Veterans Affairs.

Recently Posted Jobs

Sign up to get curated job recommendations

SoftWave TRT is Hiring for 3 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →